Kawasaki Nana, Ohta Miyako, Itoh Satsuki, Hyuga Masashi, Hyuga Sumiko, Hayakawa Takao
Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya-ku, Tokyo, 158-8501, Japan.
Biologicals. 2002 Jun;30(2):113-23. doi: 10.1006/biol.2002.0324.
We have previously reported that sugar-mapping by liquid chromatography/mass spectrometry (LC/MS) equipped with a graphitized carbon column (GCC) can be useful for structural analysis of carbohydrates in a glycoprotein. In this paper, we evaluated sugar-mapping with regard to its use in comparability assessment of glycoprotein products. Erythropoietins (EPO) produced from three different sources were chosen as models of the closely related glycoprotein products. The two-dimensional displays of sugar maps drawn by LC/MS with GCC clearly showed the differences in carbohydrate heterogeneity with regard to sialylation, acetylation, and sulphation patterns among three EPOs. Exoglycosidase digestion followed by sugar-mapping provided information regarding the structure of characteristic carbohydrates in each EPO. These results demonstrate that LC/MS with GCC can reveal the details of carbohydrate heterogeneity in order to distinguish between closely related glycoprotein products. Our method can thus be useful in comparability assessments of therapeutic glycoproteins.
我们之前曾报道,配备石墨化碳柱(GCC)的液相色谱/质谱联用(LC/MS)进行糖谱分析,可用于糖蛋白中碳水化合物的结构分析。在本文中,我们评估了糖谱分析在糖蛋白产品可比性评估中的应用。选取了三种不同来源产生的促红细胞生成素(EPO)作为密切相关糖蛋白产品的模型。用配备GCC的LC/MS绘制的糖谱二维图谱清楚地显示了三种EPO在唾液酸化、乙酰化和硫酸化模式方面碳水化合物异质性的差异。外切糖苷酶消化后进行糖谱分析,提供了关于每种EPO中特征性碳水化合物结构的信息。这些结果表明,配备GCC的LC/MS能够揭示碳水化合物异质性的细节,以便区分密切相关的糖蛋白产品。因此,我们的方法可用于治疗性糖蛋白的可比性评估。